` RGC (Regencell Bioscience Holdings Ltd) vs S&P 500 Comparison - Alpha Spread

RGC
vs
S&P 500

Over the past 12 months, RGC has significantly outperformed S&P 500, delivering a return of +3 747% compared to the S&P 500's +16% growth.

Stocks Performance
RGC vs S&P 500

Loading
RGC
S&P 500
Add Stock
www.alphaspread.com

Performance Gap
RGC vs S&P 500

Loading
RGC
S&P 500
Difference
www.alphaspread.com

Performance By Year
RGC vs S&P 500

Loading
RGC
S&P 500
Add Stock

Competitors Performance
Regencell Bioscience Holdings Ltd vs Peers

Regencell Bioscience Holdings Ltd
Glance View

Market Cap
6.8B USD
Industry
Pharmaceuticals

Regencell Bioscience Holdings Ltd. engages in the research, development, and commercialization of traditional Chinese medicine. The company employs 13 full-time employees The company went IPO on 2021-07-16. The firm launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.

RGC Intrinsic Value
Not Available
Back to Top